Sun, Y.; Veccia, D.; Liu, B.D.X.; Tse, W.; Fass, R.; Song, G.
Diagnostic Evaluation of an Increased Risk of Developing Small Intestinal Bacterial Overgrowth Associated with Glucagon-like Peptide-1 (GLP-1) Receptor Agonists and Dual GLP-1/GIP Receptor Agonists: A Global Retrospective Multicenter Cohort Analysis. Diagnostics 2025, 15, 2264.
https://doi.org/10.3390/diagnostics15172264
AMA Style
Sun Y, Veccia D, Liu BDX, Tse W, Fass R, Song G.
Diagnostic Evaluation of an Increased Risk of Developing Small Intestinal Bacterial Overgrowth Associated with Glucagon-like Peptide-1 (GLP-1) Receptor Agonists and Dual GLP-1/GIP Receptor Agonists: A Global Retrospective Multicenter Cohort Analysis. Diagnostics. 2025; 15(17):2264.
https://doi.org/10.3390/diagnostics15172264
Chicago/Turabian Style
Sun, Yan, Donovan Veccia, Benjamin Douglas Xun Liu, William Tse, Ronnie Fass, and Gengqing Song.
2025. "Diagnostic Evaluation of an Increased Risk of Developing Small Intestinal Bacterial Overgrowth Associated with Glucagon-like Peptide-1 (GLP-1) Receptor Agonists and Dual GLP-1/GIP Receptor Agonists: A Global Retrospective Multicenter Cohort Analysis" Diagnostics 15, no. 17: 2264.
https://doi.org/10.3390/diagnostics15172264
APA Style
Sun, Y., Veccia, D., Liu, B. D. X., Tse, W., Fass, R., & Song, G.
(2025). Diagnostic Evaluation of an Increased Risk of Developing Small Intestinal Bacterial Overgrowth Associated with Glucagon-like Peptide-1 (GLP-1) Receptor Agonists and Dual GLP-1/GIP Receptor Agonists: A Global Retrospective Multicenter Cohort Analysis. Diagnostics, 15(17), 2264.
https://doi.org/10.3390/diagnostics15172264
